Fortive Corporation
Fortive Corporation is an American industrial technology company that designs, manufactures, and services workplace safety instrumentation, software, and healthcare workflow solutions, generating $4,159 million in revenue from continuing operations in fiscal 2025. The company was created in July 2016 through a spin-off from Danaher, and in June 2025 it separated its Precision Technologies segment into Ralliant Corporation, reducing Fortive to two segments: Intelligent Operating Solutions (IOS) and Advanced Healthcare Solutions (AHS).
This is a file about a post-spin company at an inflection point. The Ralliant separation, completed in June 2025, triggered a sweeping refresh of Fortive's leadership, capital structure, and strategic identity. In the twelve months since, Fortive has a new CEO, a new CFO, a new CPO, $1.6 billion in share repurchases, and a refinanced debt stack. What remains is a business with enviable characteristics — the IOS segment runs at 25%+ operating margins with strong recurring revenue and iconic brands headlined by FLUKE — tethered to a healthcare segment whose margins have been a persistent disappointment. The central question is whether the post-spin Fortive can compound at a rate that justifies a valuation that already credits it for quality.
The file turns on whether AHS can close the margin gap with IOS, or whether the structural differences between selling workflow solutions to hospitals and selling test-and-measurement tools to industrial customers make that gap permanent. If the bull case — AHS at 15%+ margins, IOS compounding at mid-single digits, the buyback machine running — materialises, Fortive at these levels is a defensible compounder. If AHS stalls and IOS growth decelerates, the math behind $64 looks fragile.
Full report locked
You are viewing the public summary. The full report — business breakdown, key debates, financials, scenarios, charts and risks — is available to password holders.
Log in to read the full report →Invitation-only proof of concept. Not investment advice.